What is Pharmacogenomics?
Pharmacogenomics (PGx) is the study of how genetic variations influence the way an individual responds to medications.
PGx testing enables doctors to test for genetic variants that can predict how individuals may respond to certain medications helping to optimize medication efficacy whilst minimizing adverse effects.
With over 15 years of experience in delivering pharmacogenomic solutions worldwide and 20 years of providing genetic laboratory testing services, myDNA and its fully owned subsidiary, Gene by Gene, are world-leading providers of pharmacogenomic services across the globe. We offer access to a dedicated team of pharmacogenomic specialists, including clinical geneticists, clinical pharmacologists, molecular geneticists, bioinformaticians and pharmacists.
Tests we Offer
We offer three PGx Tests:
| myDNA Multi-Category Medication PGx Test
Covering over 160 medications used in clinical practice. Find out more about the Multiple Category Test.
| myDNA Psychotropic Medication PGx Test
Covering over 41 psychotropic medications used in clinical practice. Find out more about the Psychotropic test.
| myDNA Gene PGx MTHFR Test
Covering response to folate. Find out more about the MTHFR Test.
PGX Testing Benefits
| Reduce the risk of adverse effects
PGx testing identifies genetic variations that may increase the risk of medication adverse effects. This allows the doctor to personalize medications and enhance patient safety.
| Reduce the potential of trial and error in medication selection.
Personalizing medication and dosage selection at the outset of treatment may help patients to experience faster symptom relief and avoid unnecessary treatment delays.
| Lifelong relevance of test results
PGx test results remain valuable throughout an individual’s lifetime helping to guide future prescribing choices.